All

Results: 38473-38484 of 85815

Boyd's high capacity ROL2300 in row coolant distribution unit (CDU) efficiently and reliably cools modern high power AI processors in hyperscale, colocation, and enterprise data centers with up to a 2.3 megawatt capacity. A single ROL2300 can efficiently cool over 10 NVL72 racks. It is optimized to easily fit in data center server rows and designed to maximize service and maintenance efficiency. With high-capacity flow and pressure capabilities, customers are enabled to use fewer CDUs in AI liquid cooling applications.

Boyd Unveils a High-Capacity Coolant Distribution Unit with a 2.3 Megawatt Capacity for AI Liquid Cooling Applications

Q’s dashboard gives investor relations professionals instant insights into ownership trends, peer activity, and shareholder engagement, all in one place.

Q4 Revolutionizes Investor Relations with the Launch of Q, the First IRO Agent™

Business Wire logo

Esri Launches New E-Commerce Experience for Demographic Data

Heng Qin® is the first and only drug approved to treat DED associated with MGD and will be available to patients in China in the coming months.

Breakthrough in Ophthalmology! Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as First Treatment for Dry Eye Disease Associated with MGD

Business Wire logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

Beacon Therapeutics completes enrollment in registrational Phase 2/3 VISTA trial of laru-zova for patients with XLRP

Business Wire logo

ViaLase Announces Strategic Leadership Transitions to Support Commercial Growth

PR Newswire associated0

Lucid Air Grand Touring Wins GUINNESS WORLD RECORDS™ Title with 1,205 kilometers on a Single Charge

PR Newswire associated0

Didomi and Sourcepoint Join Forces to Build the Future of Privacy Technology

PR Newswire associated0

Lightcast Acquires Rhetorik to Expand Global People, Company, and Labor Market Intelligence

Beacon Therapeutics completes enrollment in registrational Phase 2/3 VISTA trial of laru-zova for patients with XLRP

Enterprises Enhance Privacy, Security and Control with Rackspace Technology’s OpenStack Business Private Cloud